The basis of our products lies in research intended to fulfill the needs of professionals and their patients.
All the research projects performed at Igenomix are intended for clinical use.
IGENOMIX actively works in research and has organized and participated in many national and international talks and conferences.
The result of this hard work has led to the publication of a large number of peer reviewed articles.
We use the most advanced techniques through our continuous collaboration with high profile researchers, universities and companies.
We rely on the translational research experience acquired by Prof. Carlos Simón (2011 Jaime I award-winner for Clinical Research), who led the IVI Foundation until 2016.
We have acquired broad clinical experience through our wide network of institutes specialized in reproductive medicine around the world.
Today’s advances in knowledge will lead to more comprehensive and convenient diagnostic systems to be used by patients in the future.
IGENOMIX makes a financial contribution to research, development and innovation to offer both medical professionals and patients a wide range of products and services meeting all their expectations.
At IGENOMIX, we work to develop all phases of designing diagnostic tests. From the original concept, undertaking clinical studies, producing and analyzing results, to creating products that can be commercialized, Igenomix is committed to developing each test to be backed with scientific evidence.
In the Products Development Department, we do not merely adapt already established procedures, but we innovate to provide our patients with the best services.
In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study.
Fertil Steril. 2017 May;107(5):1122-1129.
ReadPreimplantation Genetic Testing for Aneuploidies using fluorescence in situ hybridization inpatients with repetitive implantation failure and advanced maternal age: two randomized trials.
Fertil Steril. 2013 Apr;99(5):1400-7.
ReadSelection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study.
Mol Cytogenet 2012 May 2; 5(1):24.
ReadOptimal euploid embryo transfer strategy, fresh versus frozen, after Preimplantation Genetic Testing for Aneuploidies with next generation sequencing: a randomized controlled trial.
Fertil Steril. 2017 Mar;107(3):723-730.e3.
ReadDifferences in pregnancy outcomes in donor egg frozen embryo transfer (FET) cycles following Preimplantation Genetic Testing for Aneuploidies (PGT-A): a single center retrospective study.
J Assist Reprod Genet. 2017 Jan;34(1):71-78.
ReadIGENOMIX non è affiliata ad alcuna delle pubblicazioni o canali informativi elencati in precedenza. La copertura mediatica non costituisce opera di promozione di IGENOMIX o dei suoi prodotti.
